Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of TRD303 solution for postoperative analgesia after abdominal surgery
CTR20254316Phase 3Completed
- Sponsor
- Beijing Tide Pharmaceutical Co., Ltd.
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of TRD303 in postoperative pain, sponsored by Beijing Tide Pharmaceutical Co., Ltd.. Started Dec 2025; status: completed.
02
Drugs
TRD303
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20254316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254316.